Navigation Links
PDI Appoints Gerald P. Belle as Lead Independent Director
Date:7/30/2009

SADDLE RIVER, N.J., July 30 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. pharmaceutical companies, announced today that current PDI director Gerald P. Belle has been appointed to the newly-established position of lead independent director.

Mr. Belle has been a director of the Company since April 2008. He is also a member of the Audit Committee.

"Jerry has served as an invaluable board member during his tenure with PDI," stated John P. Dugan, Chairman of the Board of PDI, Inc. "In his expanded role, we believe Jerry's experience, knowledge and leadership skills will further enhance the Company's corporate governance structure. We look forward to his continuing contributions."

"I am delighted to accept this new appointment as lead director of PDI, especially as the Company continues to expand its strong presence in the industry and the value proposition it brings to its customers in an ever-changing environment. As such, I look forward to working with PDI management and my fellow board members who remain committed to helping achieve the Company's growth goals while maintaining the highest standards of corporate governance," stated Mr. Belle.

From 2004 until his retirement in November 2007, Mr. Belle served as Executive Chairman of Merial Ltd., a global animal health company that is a joint venture between Sanofi-aventis and Merck & Co. Prior to that, Mr. Belle served as President and Chief Executive Officer, North America Pharmaceuticals for Aventis, Inc. He retired after 35 years of service at Aventis and its predecessor companies. Mr. Belle is Chairman of the Board of Myriad Pharmaceuticals, Inc., a publicly traded biopharmaceutical company and also a member of the board of directors of Myriad Genetics, Inc.,
'/>"/>

SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
2. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
3. Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board
4. FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer
5. Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer
6. ERT Appoints New Vice President of Project Management
7. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
8. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
9. Progenitor Cell Therapy Appoints VP of Manufacturing Operations
10. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
11. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
Breaking Biology News(10 mins):Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2AACR names Perou 2009 Outstanding Investigator for Breast Cancer Research 2Genome BC collaborates with Chile and Norway to sequence salmon genome 2Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 1Los Angeles Kerlan Jobe Orthopaedic Clinic Pays 243 Million to Settle Kickback Allegations 62394 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 1Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 2Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 3Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 4Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 5Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 6Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 7Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 8Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 9Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 10Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 11Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 12Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 13Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 14Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 15Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 16Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 17Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 18Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 19Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 20Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 21Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 22Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 23Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 24Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 25Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 26Reportlinker Adds Emerging Clinical Trial Locations Eastern Europe 3A Market Dynamics and the Changing Healthcare and Regulatory Environment 15031 27Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 1Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 2Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 3Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 4Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 5Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 6Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 7Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 8Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 9Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 10Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 11Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 12Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 13Reportlinker Adds HPLC Systems 26amp 3B Accessories A World Market Review 6658 14